Stay updated on CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page.

Latest updates to the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now lists Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the notice about potential delays and NIH operating status due to funding lapse. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check33 days agoChange DetectedThe new screenshot exhibits the same study details with only minor visual and layout adjustments; no substantive edits to the study content or eligibility criteria were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference5%

- Check69 days agoChange DetectedCore content update includes standardizing the term to BCR-ABL1 and upgrading the revision to v3.1.0; additions introduce new identifiers (number and email addresses) with minor relevance to contact-like data.SummaryDifference0.4%

- Check83 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed; no other content changes.SummaryDifference0.3%

Stay in the know with updates to CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page.